nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2B6—Simvastatin—atherosclerosis	0.0709	0.101	CbGbCtD
Nevirapine—CYP3A5—Rosuvastatin—atherosclerosis	0.0601	0.0854	CbGbCtD
Nevirapine—CYP3A5—Simvastatin—atherosclerosis	0.0559	0.0794	CbGbCtD
Nevirapine—CYP3A5—Lovastatin—atherosclerosis	0.0547	0.0777	CbGbCtD
Nevirapine—CYP3A5—Pravastatin—atherosclerosis	0.0547	0.0777	CbGbCtD
Nevirapine—CYP2D6—Niacin—atherosclerosis	0.0434	0.0616	CbGbCtD
Nevirapine—CYP2C9—Rosuvastatin—atherosclerosis	0.0403	0.0573	CbGbCtD
Nevirapine—CYP2C9—Simvastatin—atherosclerosis	0.0375	0.0533	CbGbCtD
Nevirapine—CYP2C9—Pravastatin—atherosclerosis	0.0367	0.0521	CbGbCtD
Nevirapine—CYP2C9—Lovastatin—atherosclerosis	0.0367	0.0521	CbGbCtD
Nevirapine—CYP2D6—Simvastatin—atherosclerosis	0.0343	0.0487	CbGbCtD
Nevirapine—CYP2D6—Lovastatin—atherosclerosis	0.0335	0.0477	CbGbCtD
Nevirapine—CYP2D6—Pravastatin—atherosclerosis	0.0335	0.0477	CbGbCtD
Nevirapine—CYP3A4—Ezetimibe—atherosclerosis	0.0234	0.0333	CbGbCtD
Nevirapine—CYP3A4—Rosuvastatin—atherosclerosis	0.0234	0.0333	CbGbCtD
Nevirapine—CYP3A4—Simvastatin—atherosclerosis	0.0218	0.031	CbGbCtD
Nevirapine—CYP3A4—Lovastatin—atherosclerosis	0.0213	0.0303	CbGbCtD
Nevirapine—CYP3A4—Pravastatin—atherosclerosis	0.0213	0.0303	CbGbCtD
Nevirapine—Transaminases increased—Pravastatin—atherosclerosis	0.00191	0.00775	CcSEcCtD
Nevirapine—Liver disorder—Simvastatin—atherosclerosis	0.00189	0.00765	CcSEcCtD
Nevirapine—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00183	0.00744	CcSEcCtD
Nevirapine—Drug interaction—Rosuvastatin—atherosclerosis	0.00175	0.00709	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00172	0.00696	CcSEcCtD
Nevirapine—Liver disorder—Pravastatin—atherosclerosis	0.00171	0.00692	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00164	0.00665	CcSEcCtD
Nevirapine—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00155	0.0063	CcSEcCtD
Nevirapine—Hepatotoxicity—Niacin—atherosclerosis	0.00153	0.0062	CcSEcCtD
Nevirapine—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00152	0.00618	CcSEcCtD
Nevirapine—Necrosis—Niacin—atherosclerosis	0.0015	0.0061	CcSEcCtD
Nevirapine—Bone disorder—Ezetimibe—atherosclerosis	0.00149	0.00606	CcSEcCtD
Nevirapine—Drug interaction—Ezetimibe—atherosclerosis	0.00145	0.0059	CcSEcCtD
Nevirapine—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00145	0.0059	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.00141	0.00573	CcSEcCtD
Nevirapine—Inflammation—Ezetimibe—atherosclerosis	0.00139	0.00564	CcSEcCtD
Nevirapine—Drug interaction—Simvastatin—atherosclerosis	0.00139	0.00562	CcSEcCtD
Nevirapine—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00135	0.00547	CcSEcCtD
Nevirapine—Rhabdomyolysis—Niacin—atherosclerosis	0.00133	0.00541	CcSEcCtD
Nevirapine—Inflammation—Simvastatin—atherosclerosis	0.00133	0.00538	CcSEcCtD
Nevirapine—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00131	0.00533	CcSEcCtD
Nevirapine—Hepatic failure—Rosuvastatin—atherosclerosis	0.00131	0.00532	CcSEcCtD
Nevirapine—Bone disorder—Niacin—atherosclerosis	0.00131	0.0053	CcSEcCtD
Nevirapine—Hepatocellular injury—Simvastatin—atherosclerosis	0.00129	0.00522	CcSEcCtD
Nevirapine—Drug interaction—Pravastatin—atherosclerosis	0.00125	0.00508	CcSEcCtD
Nevirapine—Hepatocellular injury—Pravastatin—atherosclerosis	0.00116	0.00472	CcSEcCtD
Nevirapine—Skin exfoliation—Niacin—atherosclerosis	0.00113	0.00457	CcSEcCtD
Nevirapine—Hepatic failure—Lovastatin—atherosclerosis	0.00111	0.0045	CcSEcCtD
Nevirapine—Hepatic failure—Ezetimibe—atherosclerosis	0.00109	0.00442	CcSEcCtD
Nevirapine—Rash maculo-papular—Niacin—atherosclerosis	0.00107	0.00435	CcSEcCtD
Nevirapine—Hepatic failure—Simvastatin—atherosclerosis	0.00104	0.00421	CcSEcCtD
Nevirapine—Pancreatitis—Rosuvastatin—atherosclerosis	0.000998	0.00405	CcSEcCtD
Nevirapine—Hepatic failure—Pravastatin—atherosclerosis	0.000939	0.00381	CcSEcCtD
Nevirapine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000904	0.00367	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.000899	0.00365	CcSEcCtD
Nevirapine—Dermatitis bullous—Niacin—atherosclerosis	0.000897	0.00364	CcSEcCtD
Nevirapine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00089	0.00361	CcSEcCtD
Nevirapine—Jaundice—Rosuvastatin—atherosclerosis	0.000885	0.00359	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000882	0.00358	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000864	0.0035	CcSEcCtD
Nevirapine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000859	0.00348	CcSEcCtD
Nevirapine—Eosinophilia—Lovastatin—atherosclerosis	0.000854	0.00346	CcSEcCtD
Nevirapine—Pancreatitis—Lovastatin—atherosclerosis	0.000846	0.00343	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000841	0.00341	CcSEcCtD
Nevirapine—Eosinophilia—Ezetimibe—atherosclerosis	0.000838	0.0034	CcSEcCtD
Nevirapine—Pancreatitis—Ezetimibe—atherosclerosis	0.00083	0.00336	CcSEcCtD
Nevirapine—Face oedema—Niacin—atherosclerosis	0.000828	0.00336	CcSEcCtD
Nevirapine—Hepatitis—Rosuvastatin—atherosclerosis	0.000815	0.0033	CcSEcCtD
Nevirapine—Eosinophilia—Simvastatin—atherosclerosis	0.000799	0.00324	CcSEcCtD
Nevirapine—Liver function test abnormal—Niacin—atherosclerosis	0.000792	0.00321	CcSEcCtD
Nevirapine—Pancreatitis—Simvastatin—atherosclerosis	0.000791	0.00321	CcSEcCtD
Nevirapine—Liver function test abnormal—Pravastatin—atherosclerosis	0.000779	0.00316	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000763	0.00309	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00076	0.00308	CcSEcCtD
Nevirapine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000754	0.00306	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000745	0.00302	CcSEcCtD
Nevirapine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00074	0.003	CcSEcCtD
Nevirapine—Jaundice—Ezetimibe—atherosclerosis	0.000736	0.00298	CcSEcCtD
Nevirapine—Eosinophilia—Pravastatin—atherosclerosis	0.000722	0.00293	CcSEcCtD
Nevirapine—Pancreatitis—Pravastatin—atherosclerosis	0.000715	0.0029	CcSEcCtD
Nevirapine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000714	0.00289	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000713	0.00289	CcSEcCtD
Nevirapine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000705	0.00286	CcSEcCtD
Nevirapine—Jaundice—Simvastatin—atherosclerosis	0.000701	0.00284	CcSEcCtD
Nevirapine—Hepatitis—Lovastatin—atherosclerosis	0.000691	0.0028	CcSEcCtD
Nevirapine—Hepatitis—Ezetimibe—atherosclerosis	0.000677	0.00275	CcSEcCtD
Nevirapine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000666	0.0027	CcSEcCtD
Nevirapine—Erythema multiforme—Lovastatin—atherosclerosis	0.000653	0.00265	CcSEcCtD
Nevirapine—Angioedema—Rosuvastatin—atherosclerosis	0.000648	0.00263	CcSEcCtD
Nevirapine—Hepatitis—Simvastatin—atherosclerosis	0.000646	0.00262	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000645	0.00262	CcSEcCtD
Nevirapine—Jaundice—Niacin—atherosclerosis	0.000644	0.00261	CcSEcCtD
Nevirapine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00064	0.0026	CcSEcCtD
Nevirapine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000638	0.00259	CcSEcCtD
Nevirapine—Jaundice—Pravastatin—atherosclerosis	0.000634	0.00257	CcSEcCtD
Nevirapine—Immune system disorder—Ezetimibe—atherosclerosis	0.000612	0.00248	CcSEcCtD
Nevirapine—Erythema multiforme—Simvastatin—atherosclerosis	0.000611	0.00248	CcSEcCtD
Nevirapine—Myalgia—Rosuvastatin—atherosclerosis	0.000604	0.00245	CcSEcCtD
Nevirapine—Arthralgia—Rosuvastatin—atherosclerosis	0.000604	0.00245	CcSEcCtD
Nevirapine—Hepatitis—Niacin—atherosclerosis	0.000593	0.00241	CcSEcCtD
Nevirapine—Erythema—Ezetimibe—atherosclerosis	0.00059	0.00239	CcSEcCtD
Nevirapine—Hepatitis—Pravastatin—atherosclerosis	0.000584	0.00237	CcSEcCtD
Nevirapine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000568	0.0023	CcSEcCtD
Nevirapine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000567	0.0023	CcSEcCtD
Nevirapine—Erythema—Simvastatin—atherosclerosis	0.000562	0.00228	CcSEcCtD
Nevirapine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000558	0.00226	CcSEcCtD
Nevirapine—Erythema multiforme—Pravastatin—atherosclerosis	0.000552	0.00224	CcSEcCtD
Nevirapine—Angioedema—Lovastatin—atherosclerosis	0.000549	0.00223	CcSEcCtD
Nevirapine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000547	0.00222	CcSEcCtD
Nevirapine—Anaemia—Ezetimibe—atherosclerosis	0.000545	0.00221	CcSEcCtD
Nevirapine—Malaise—Lovastatin—atherosclerosis	0.000542	0.0022	CcSEcCtD
Nevirapine—Angioedema—Ezetimibe—atherosclerosis	0.000539	0.00218	CcSEcCtD
Nevirapine—Malaise—Ezetimibe—atherosclerosis	0.000532	0.00216	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000528	0.00214	CcSEcCtD
Nevirapine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000522	0.00212	CcSEcCtD
Nevirapine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00052	0.00211	CcSEcCtD
Nevirapine—Anaemia—Simvastatin—atherosclerosis	0.00052	0.00211	CcSEcCtD
Nevirapine—Erythema—Niacin—atherosclerosis	0.000516	0.00209	CcSEcCtD
Nevirapine—Angioedema—Simvastatin—atherosclerosis	0.000514	0.00208	CcSEcCtD
Nevirapine—Arthralgia—Lovastatin—atherosclerosis	0.000512	0.00208	CcSEcCtD
Nevirapine—Myalgia—Lovastatin—atherosclerosis	0.000512	0.00208	CcSEcCtD
Nevirapine—Malaise—Simvastatin—atherosclerosis	0.000507	0.00206	CcSEcCtD
Nevirapine—Discomfort—Lovastatin—atherosclerosis	0.000506	0.00205	CcSEcCtD
Nevirapine—Arthralgia—Ezetimibe—atherosclerosis	0.000502	0.00204	CcSEcCtD
Nevirapine—Myalgia—Ezetimibe—atherosclerosis	0.000502	0.00204	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000499	0.00202	CcSEcCtD
Nevirapine—Discomfort—Ezetimibe—atherosclerosis	0.000496	0.00201	CcSEcCtD
Nevirapine—Pain—Rosuvastatin—atherosclerosis	0.000495	0.00201	CcSEcCtD
Nevirapine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000491	0.00199	CcSEcCtD
Nevirapine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000481	0.00195	CcSEcCtD
Nevirapine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00048	0.00195	CcSEcCtD
Nevirapine—Myalgia—Simvastatin—atherosclerosis	0.000479	0.00194	CcSEcCtD
Nevirapine—Arthralgia—Simvastatin—atherosclerosis	0.000479	0.00194	CcSEcCtD
Nevirapine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000477	0.00193	CcSEcCtD
Nevirapine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000473	0.00192	CcSEcCtD
Nevirapine—Discomfort—Simvastatin—atherosclerosis	0.000473	0.00192	CcSEcCtD
Nevirapine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000472	0.00191	CcSEcCtD
Nevirapine—Angioedema—Niacin—atherosclerosis	0.000472	0.00191	CcSEcCtD
Nevirapine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000472	0.00191	CcSEcCtD
Nevirapine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000471	0.00191	CcSEcCtD
Nevirapine—Anaemia—Pravastatin—atherosclerosis	0.00047	0.00191	CcSEcCtD
Nevirapine—Anorexia—Lovastatin—atherosclerosis	0.000468	0.0019	CcSEcCtD
Nevirapine—Skin disorder—Ezetimibe—atherosclerosis	0.000467	0.0019	CcSEcCtD
Nevirapine—Angioedema—Pravastatin—atherosclerosis	0.000465	0.00188	CcSEcCtD
Nevirapine—Urticaria—Rosuvastatin—atherosclerosis	0.00046	0.00187	CcSEcCtD
Nevirapine—Oedema—Simvastatin—atherosclerosis	0.000459	0.00186	CcSEcCtD
Nevirapine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000459	0.00186	CcSEcCtD
Nevirapine—Malaise—Pravastatin—atherosclerosis	0.000458	0.00186	CcSEcCtD
Nevirapine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000458	0.00186	CcSEcCtD
Nevirapine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000449	0.00182	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000447	0.00181	CcSEcCtD
Nevirapine—Paraesthesia—Lovastatin—atherosclerosis	0.000441	0.00179	CcSEcCtD
Nevirapine—Myalgia—Niacin—atherosclerosis	0.00044	0.00178	CcSEcCtD
Nevirapine—Arthralgia—Niacin—atherosclerosis	0.00044	0.00178	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000438	0.00178	CcSEcCtD
Nevirapine—Anorexia—Simvastatin—atherosclerosis	0.000437	0.00177	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000437	0.00177	CcSEcCtD
Nevirapine—Arthralgia—Pravastatin—atherosclerosis	0.000433	0.00176	CcSEcCtD
Nevirapine—Myalgia—Pravastatin—atherosclerosis	0.000433	0.00176	CcSEcCtD
Nevirapine—Paraesthesia—Ezetimibe—atherosclerosis	0.000432	0.00175	CcSEcCtD
Nevirapine—Discomfort—Pravastatin—atherosclerosis	0.000428	0.00173	CcSEcCtD
Nevirapine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000427	0.00173	CcSEcCtD
Nevirapine—Decreased appetite—Lovastatin—atherosclerosis	0.000427	0.00173	CcSEcCtD
Nevirapine—Fatigue—Lovastatin—atherosclerosis	0.000423	0.00172	CcSEcCtD
Nevirapine—Anaphylactic shock—Niacin—atherosclerosis	0.000421	0.00171	CcSEcCtD
Nevirapine—Oedema—Niacin—atherosclerosis	0.000421	0.00171	CcSEcCtD
Nevirapine—Pain—Lovastatin—atherosclerosis	0.00042	0.0017	CcSEcCtD
Nevirapine—Decreased appetite—Ezetimibe—atherosclerosis	0.000418	0.0017	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000418	0.0017	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000415	0.00168	CcSEcCtD
Nevirapine—Asthenia—Rosuvastatin—atherosclerosis	0.000415	0.00168	CcSEcCtD
Nevirapine—Oedema—Pravastatin—atherosclerosis	0.000415	0.00168	CcSEcCtD
Nevirapine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000415	0.00168	CcSEcCtD
Nevirapine—Fatigue—Ezetimibe—atherosclerosis	0.000415	0.00168	CcSEcCtD
Nevirapine—Paraesthesia—Simvastatin—atherosclerosis	0.000412	0.00167	CcSEcCtD
Nevirapine—Pain—Ezetimibe—atherosclerosis	0.000412	0.00167	CcSEcCtD
Nevirapine—Pruritus—Rosuvastatin—atherosclerosis	0.00041	0.00166	CcSEcCtD
Nevirapine—Skin disorder—Niacin—atherosclerosis	0.000409	0.00166	CcSEcCtD
Nevirapine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000406	0.00165	CcSEcCtD
Nevirapine—Feeling abnormal—Lovastatin—atherosclerosis	0.000404	0.00164	CcSEcCtD
Nevirapine—Anorexia—Niacin—atherosclerosis	0.000402	0.00163	CcSEcCtD
Nevirapine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000401	0.00163	CcSEcCtD
Nevirapine—Decreased appetite—Simvastatin—atherosclerosis	0.000399	0.00162	CcSEcCtD
Nevirapine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000397	0.00161	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000396	0.00161	CcSEcCtD
Nevirapine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000396	0.00161	CcSEcCtD
Nevirapine—Fatigue—Simvastatin—atherosclerosis	0.000396	0.0016	CcSEcCtD
Nevirapine—Anorexia—Pravastatin—atherosclerosis	0.000396	0.0016	CcSEcCtD
Nevirapine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000394	0.0016	CcSEcCtD
Nevirapine—Pain—Simvastatin—atherosclerosis	0.000392	0.00159	CcSEcCtD
Nevirapine—Urticaria—Lovastatin—atherosclerosis	0.00039	0.00158	CcSEcCtD
Nevirapine—Abdominal pain—Lovastatin—atherosclerosis	0.000388	0.00157	CcSEcCtD
Nevirapine—Body temperature increased—Lovastatin—atherosclerosis	0.000388	0.00157	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000384	0.00156	CcSEcCtD
Nevirapine—Urticaria—Ezetimibe—atherosclerosis	0.000382	0.00155	CcSEcCtD
Nevirapine—Abdominal pain—Ezetimibe—atherosclerosis	0.00038	0.00154	CcSEcCtD
Nevirapine—Body temperature increased—Ezetimibe—atherosclerosis	0.00038	0.00154	CcSEcCtD
Nevirapine—Paraesthesia—Niacin—atherosclerosis	0.000378	0.00153	CcSEcCtD
Nevirapine—Feeling abnormal—Simvastatin—atherosclerosis	0.000378	0.00153	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000378	0.00153	CcSEcCtD
Nevirapine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000375	0.00152	CcSEcCtD
Nevirapine—Somnolence—Niacin—atherosclerosis	0.000375	0.00152	CcSEcCtD
Nevirapine—Paraesthesia—Pravastatin—atherosclerosis	0.000373	0.00151	CcSEcCtD
Nevirapine—Decreased appetite—Niacin—atherosclerosis	0.000366	0.00149	CcSEcCtD
Nevirapine—Rash—Rosuvastatin—atherosclerosis	0.000365	0.00148	CcSEcCtD
Nevirapine—Dermatitis—Rosuvastatin—atherosclerosis	0.000365	0.00148	CcSEcCtD
Nevirapine—Urticaria—Simvastatin—atherosclerosis	0.000365	0.00148	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000364	0.00148	CcSEcCtD
Nevirapine—Body temperature increased—Simvastatin—atherosclerosis	0.000363	0.00147	CcSEcCtD
Nevirapine—Abdominal pain—Simvastatin—atherosclerosis	0.000363	0.00147	CcSEcCtD
Nevirapine—Headache—Rosuvastatin—atherosclerosis	0.000363	0.00147	CcSEcCtD
Nevirapine—Hypersensitivity—Lovastatin—atherosclerosis	0.000362	0.00147	CcSEcCtD
Nevirapine—Decreased appetite—Pravastatin—atherosclerosis	0.000361	0.00146	CcSEcCtD
Nevirapine—Pain—Niacin—atherosclerosis	0.00036	0.00146	CcSEcCtD
Nevirapine—Fatigue—Pravastatin—atherosclerosis	0.000358	0.00145	CcSEcCtD
Nevirapine—Pain—Pravastatin—atherosclerosis	0.000355	0.00144	CcSEcCtD
Nevirapine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000355	0.00144	CcSEcCtD
Nevirapine—Asthenia—Lovastatin—atherosclerosis	0.000352	0.00143	CcSEcCtD
Nevirapine—Pruritus—Lovastatin—atherosclerosis	0.000347	0.00141	CcSEcCtD
Nevirapine—Asthenia—Ezetimibe—atherosclerosis	0.000345	0.0014	CcSEcCtD
Nevirapine—Gastrointestinal pain—Niacin—atherosclerosis	0.000345	0.0014	CcSEcCtD
Nevirapine—Nausea—Rosuvastatin—atherosclerosis	0.000344	0.00139	CcSEcCtD
Nevirapine—Feeling abnormal—Pravastatin—atherosclerosis	0.000342	0.00139	CcSEcCtD
Nevirapine—Pruritus—Ezetimibe—atherosclerosis	0.00034	0.00138	CcSEcCtD
Nevirapine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000339	0.00138	CcSEcCtD
Nevirapine—Hypersensitivity—Simvastatin—atherosclerosis	0.000338	0.00137	CcSEcCtD
Nevirapine—Diarrhoea—Lovastatin—atherosclerosis	0.000336	0.00136	CcSEcCtD
Nevirapine—Urticaria—Niacin—atherosclerosis	0.000335	0.00136	CcSEcCtD
Nevirapine—Abdominal pain—Niacin—atherosclerosis	0.000333	0.00135	CcSEcCtD
Nevirapine—Body temperature increased—Niacin—atherosclerosis	0.000333	0.00135	CcSEcCtD
Nevirapine—Urticaria—Pravastatin—atherosclerosis	0.00033	0.00134	CcSEcCtD
Nevirapine—Asthenia—Simvastatin—atherosclerosis	0.000329	0.00134	CcSEcCtD
Nevirapine—Diarrhoea—Ezetimibe—atherosclerosis	0.000329	0.00134	CcSEcCtD
Nevirapine—Abdominal pain—Pravastatin—atherosclerosis	0.000328	0.00133	CcSEcCtD
Nevirapine—Body temperature increased—Pravastatin—atherosclerosis	0.000328	0.00133	CcSEcCtD
Nevirapine—Pruritus—Simvastatin—atherosclerosis	0.000325	0.00132	CcSEcCtD
Nevirapine—Diarrhoea—Simvastatin—atherosclerosis	0.000314	0.00127	CcSEcCtD
Nevirapine—Vomiting—Lovastatin—atherosclerosis	0.000312	0.00127	CcSEcCtD
Nevirapine—Hypersensitivity—Niacin—atherosclerosis	0.00031	0.00126	CcSEcCtD
Nevirapine—Rash—Lovastatin—atherosclerosis	0.000309	0.00125	CcSEcCtD
Nevirapine—Dermatitis—Lovastatin—atherosclerosis	0.000309	0.00125	CcSEcCtD
Nevirapine—Headache—Lovastatin—atherosclerosis	0.000307	0.00125	CcSEcCtD
Nevirapine—Vomiting—Ezetimibe—atherosclerosis	0.000306	0.00124	CcSEcCtD
Nevirapine—Hypersensitivity—Pravastatin—atherosclerosis	0.000306	0.00124	CcSEcCtD
Nevirapine—Rash—Ezetimibe—atherosclerosis	0.000303	0.00123	CcSEcCtD
Nevirapine—Dermatitis—Ezetimibe—atherosclerosis	0.000303	0.00123	CcSEcCtD
Nevirapine—Asthenia—Niacin—atherosclerosis	0.000302	0.00123	CcSEcCtD
Nevirapine—Headache—Ezetimibe—atherosclerosis	0.000301	0.00122	CcSEcCtD
Nevirapine—Pruritus—Niacin—atherosclerosis	0.000298	0.00121	CcSEcCtD
Nevirapine—Asthenia—Pravastatin—atherosclerosis	0.000298	0.00121	CcSEcCtD
Nevirapine—Pruritus—Pravastatin—atherosclerosis	0.000294	0.00119	CcSEcCtD
Nevirapine—Vomiting—Simvastatin—atherosclerosis	0.000292	0.00118	CcSEcCtD
Nevirapine—Nausea—Lovastatin—atherosclerosis	0.000291	0.00118	CcSEcCtD
Nevirapine—Rash—Simvastatin—atherosclerosis	0.000289	0.00117	CcSEcCtD
Nevirapine—Dermatitis—Simvastatin—atherosclerosis	0.000289	0.00117	CcSEcCtD
Nevirapine—Diarrhoea—Niacin—atherosclerosis	0.000288	0.00117	CcSEcCtD
Nevirapine—Headache—Simvastatin—atherosclerosis	0.000288	0.00117	CcSEcCtD
Nevirapine—Nausea—Ezetimibe—atherosclerosis	0.000286	0.00116	CcSEcCtD
Nevirapine—Diarrhoea—Pravastatin—atherosclerosis	0.000284	0.00115	CcSEcCtD
Nevirapine—Nausea—Simvastatin—atherosclerosis	0.000273	0.00111	CcSEcCtD
Nevirapine—Vomiting—Niacin—atherosclerosis	0.000268	0.00109	CcSEcCtD
Nevirapine—Rash—Niacin—atherosclerosis	0.000266	0.00108	CcSEcCtD
Nevirapine—Dermatitis—Niacin—atherosclerosis	0.000265	0.00108	CcSEcCtD
Nevirapine—Headache—Niacin—atherosclerosis	0.000264	0.00107	CcSEcCtD
Nevirapine—Vomiting—Pravastatin—atherosclerosis	0.000264	0.00107	CcSEcCtD
Nevirapine—Rash—Pravastatin—atherosclerosis	0.000262	0.00106	CcSEcCtD
Nevirapine—Dermatitis—Pravastatin—atherosclerosis	0.000261	0.00106	CcSEcCtD
Nevirapine—Headache—Pravastatin—atherosclerosis	0.00026	0.00105	CcSEcCtD
Nevirapine—Nausea—Niacin—atherosclerosis	0.00025	0.00102	CcSEcCtD
Nevirapine—Nausea—Pravastatin—atherosclerosis	0.000246	0.000999	CcSEcCtD
Nevirapine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.73e-05	0.000347	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.73e-05	0.000347	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.71e-05	0.000343	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CETP—atherosclerosis	1.71e-05	0.000343	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.67e-05	0.000336	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.67e-05	0.000335	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LCAT—atherosclerosis	1.66e-05	0.000334	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—FABP4—atherosclerosis	1.66e-05	0.000334	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA2—atherosclerosis	1.66e-05	0.000333	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.66e-05	0.000333	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.66e-05	0.000333	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.66e-05	0.000333	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA2—atherosclerosis	1.65e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.65e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.65e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.65e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.64e-05	0.000329	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.63e-05	0.000328	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA4—atherosclerosis	1.63e-05	0.000328	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.62e-05	0.000326	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.62e-05	0.000326	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.6e-05	0.000322	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LPA—atherosclerosis	1.58e-05	0.000318	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.58e-05	0.000317	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LPA—atherosclerosis	1.57e-05	0.000315	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.54e-05	0.00031	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BGN—atherosclerosis	1.53e-05	0.000308	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.53e-05	0.000307	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BGN—atherosclerosis	1.52e-05	0.000305	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.52e-05	0.000305	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.51e-05	0.000303	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA5—atherosclerosis	1.5e-05	0.000302	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—HMOX1—atherosclerosis	1.5e-05	0.0003	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.48e-05	0.000298	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.46e-05	0.000293	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.46e-05	0.000293	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.46e-05	0.000293	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.45e-05	0.000291	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOB—atherosclerosis	1.43e-05	0.000288	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.43e-05	0.000287	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.42e-05	0.000286	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.42e-05	0.000285	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.42e-05	0.000284	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.41e-05	0.000283	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.41e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.41e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.41e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.41e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.41e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.4e-05	0.000281	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTM1—atherosclerosis	1.39e-05	0.00028	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.39e-05	0.000279	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.39e-05	0.000278	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.38e-05	0.000276	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—LPL—atherosclerosis	1.37e-05	0.000275	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.37e-05	0.000274	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LPA—atherosclerosis	1.34e-05	0.000269	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GPX1—atherosclerosis	1.34e-05	0.000268	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CD36—atherosclerosis	1.3e-05	0.000261	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BGN—atherosclerosis	1.3e-05	0.000261	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.29e-05	0.000259	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.29e-05	0.000259	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.29e-05	0.000258	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.28e-05	0.000258	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.28e-05	0.000258	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.27e-05	0.000254	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.26e-05	0.000253	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.26e-05	0.000252	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.25e-05	0.000252	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.25e-05	0.000251	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.25e-05	0.000251	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.25e-05	0.00025	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LIPC—atherosclerosis	1.25e-05	0.00025	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.24e-05	0.000249	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOC3—atherosclerosis	1.24e-05	0.000249	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.24e-05	0.000249	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.24e-05	0.000248	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MTHFR—atherosclerosis	1.23e-05	0.000247	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LDLR—atherosclerosis	1.23e-05	0.000247	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.22e-05	0.000246	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CETP—atherosclerosis	1.21e-05	0.000244	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.21e-05	0.000243	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.21e-05	0.000243	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARA—atherosclerosis	1.21e-05	0.000243	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.21e-05	0.000242	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CETP—atherosclerosis	1.2e-05	0.000241	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.2e-05	0.00024	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.18e-05	0.000237	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AGT—atherosclerosis	1.17e-05	0.000235	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.16e-05	0.000233	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOB—atherosclerosis	1.16e-05	0.000232	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.15e-05	0.000231	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOE—atherosclerosis	1.15e-05	0.00023	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.14e-05	0.00023	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAV1—atherosclerosis	1.14e-05	0.000228	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOA1—atherosclerosis	1.13e-05	0.000228	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOB—atherosclerosis	1.13e-05	0.000227	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.12e-05	0.000226	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.12e-05	0.000225	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.1e-05	0.000222	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—LPL—atherosclerosis	1.1e-05	0.000222	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.1e-05	0.000221	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.1e-05	0.00022	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.09e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.08e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.08e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.08e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.08e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—LPL—atherosclerosis	1.08e-05	0.000217	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPX1—atherosclerosis	1.08e-05	0.000216	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.07e-05	0.000215	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.07e-05	0.000215	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.07e-05	0.000214	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.07e-05	0.000214	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.06e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—atherosclerosis	1.05e-05	0.000211	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.05e-05	0.000211	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CD36—atherosclerosis	1.05e-05	0.000211	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.04e-05	0.000208	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPA—atherosclerosis	1.04e-05	0.000208	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CETP—atherosclerosis	1.03e-05	0.000206	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CD36—atherosclerosis	1.03e-05	0.000206	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BGN—atherosclerosis	1e-05	0.000201	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—atherosclerosis	9.99e-06	0.000201	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—atherosclerosis	9.94e-06	0.0002	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA5—atherosclerosis	9.92e-06	0.000199	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.84e-06	0.000198	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.81e-06	0.000197	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—INS—atherosclerosis	9.8e-06	0.000197	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.78e-06	0.000196	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARA—atherosclerosis	9.75e-06	0.000196	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—atherosclerosis	9.72e-06	0.000195	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCA1—atherosclerosis	9.7e-06	0.000195	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.58e-06	0.000192	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.55e-06	0.000192	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARA—atherosclerosis	9.53e-06	0.000191	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AGT—atherosclerosis	9.45e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMGCR—atherosclerosis	9.3e-06	0.000187	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOE—atherosclerosis	9.26e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AGT—atherosclerosis	9.23e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.23e-06	0.000185	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAV1—atherosclerosis	9.17e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOA1—atherosclerosis	9.15e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOE—atherosclerosis	9.05e-06	0.000182	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—atherosclerosis	8.98e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAV1—atherosclerosis	8.96e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOA1—atherosclerosis	8.94e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NOS3—atherosclerosis	8.59e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.39e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.38e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	8.35e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—atherosclerosis	8.32e-06	0.000167	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.29e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.27e-06	0.000166	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LIPC—atherosclerosis	8.22e-06	0.000165	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOC3—atherosclerosis	8.17e-06	0.000164	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8.16e-06	0.000164	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LDLR—atherosclerosis	8.12e-06	0.000163	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—atherosclerosis	8.06e-06	0.000162	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOB—atherosclerosis	8.04e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOB—atherosclerosis	7.97e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CETP—atherosclerosis	7.93e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—INS—atherosclerosis	7.91e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—atherosclerosis	7.88e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—atherosclerosis	7.86e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.82e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.75e-06	0.000156	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—INS—atherosclerosis	7.73e-06	0.000155	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LPL—atherosclerosis	7.67e-06	0.000154	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LPL—atherosclerosis	7.61e-06	0.000153	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.6e-06	0.000152	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—atherosclerosis	7.49e-06	0.00015	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—atherosclerosis	7.42e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CD36—atherosclerosis	7.29e-06	0.000146	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—atherosclerosis	7.25e-06	0.000146	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CD36—atherosclerosis	7.23e-06	0.000145	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.17e-06	0.000144	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.11e-06	0.000143	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—atherosclerosis	7.09e-06	0.000142	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NOS3—atherosclerosis	6.93e-06	0.000139	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.91e-06	0.000139	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.85e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOB—atherosclerosis	6.81e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARA—atherosclerosis	6.78e-06	0.000136	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NOS3—atherosclerosis	6.78e-06	0.000136	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARA—atherosclerosis	6.72e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.62e-06	0.000133	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AGT—atherosclerosis	6.57e-06	0.000132	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AGT—atherosclerosis	6.51e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LPL—atherosclerosis	6.5e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOE—atherosclerosis	6.43e-06	0.000129	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.39e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOE—atherosclerosis	6.38e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAV1—atherosclerosis	6.37e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA1—atherosclerosis	6.36e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—atherosclerosis	6.34e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—atherosclerosis	6.34e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAV1—atherosclerosis	6.32e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA1—atherosclerosis	6.3e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.2e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CD36—atherosclerosis	6.18e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.85e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.81e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.76e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARA—atherosclerosis	5.74e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—atherosclerosis	5.6e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AGT—atherosclerosis	5.56e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—atherosclerosis	5.55e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—INS—atherosclerosis	5.5e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.49e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOE—atherosclerosis	5.45e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—INS—atherosclerosis	5.45e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAV1—atherosclerosis	5.4e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA1—atherosclerosis	5.39e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOB—atherosclerosis	5.25e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.11e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—atherosclerosis	5.04e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPL—atherosclerosis	5.02e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—atherosclerosis	4.99e-06	0.0001	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.92e-06	9.87e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.9e-06	9.83e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NOS3—atherosclerosis	4.82e-06	9.67e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NOS3—atherosclerosis	4.78e-06	9.59e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CD36—atherosclerosis	4.77e-06	9.57e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—atherosclerosis	4.75e-06	9.53e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—INS—atherosclerosis	4.66e-06	9.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.52e-06	9.07e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARA—atherosclerosis	4.43e-06	8.9e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.41e-06	8.85e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.37e-06	8.77e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AGT—atherosclerosis	4.29e-06	8.62e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—atherosclerosis	4.27e-06	8.57e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOE—atherosclerosis	4.21e-06	8.44e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAV1—atherosclerosis	4.17e-06	8.37e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA1—atherosclerosis	4.16e-06	8.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NOS3—atherosclerosis	4.08e-06	8.2e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—atherosclerosis	3.95e-06	7.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.8e-06	7.62e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.73e-06	7.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.66e-06	7.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—INS—atherosclerosis	3.59e-06	7.21e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—atherosclerosis	3.29e-06	6.61e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—atherosclerosis	3.19e-06	6.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.15e-06	6.33e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—atherosclerosis	3.12e-06	6.25e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.88e-06	5.79e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.22e-06	4.45e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—atherosclerosis	2.2e-06	4.41e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.88e-06	3.77e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.45e-06	2.91e-05	CbGpPWpGaD
